EGFR and lung adenocarcinoma: According to the Catalogue of Somatic Mutations in Cancer (COSMIC) (v66) database, 9.5% (524 of 5544 reported cases) of the EGFR mutations in lung adenocarcinoma may be undetected by modern MtS methods [32], a finding which was similar to that of our study.